Impact of Behavioral and Psychosocial Factors on Relapse among Persons with Substance Use Disorder

Jawwad Muhammad Shujaat; Dr. Muhammad Akram Riaz; Muhammad Naveed Riaz; Dr. Masud Akhtar; Prof. Dr. Muhammad Iqbal Chaudhry

Authors

Jawwad Muhammad Shujaat Govt. Mian Muhammad Nawaz Sharif Associate College, Sargodha
Dr. Muhammad Akram Riaz The University of Lahore, Sargodha Campus
Muhammad Naveed Riaz University of Sargodha, Sargodha
Dr. Masud Akhtar The University of Lahore, Sargodha Campus
Prof. Dr. Muhammad Iqbal Chaudhry Sargodha Campus, Superior University

Abstract

The present study was conducted to explore the impact of behavioral factors on relapse among drug addicts and moderating role of psychological factors. The study was carried out on male drug addicts from different cities in Punjab. The sample was comprised of (N = 200) male drug addicts. The sample was selected by using purposive sampling. The General Health Questionnaire, Patient Depression Questionnaire PHQ-9, Drug Abuse Screening Test-10, Perceived Stigma of Substance Abuse Scale, Adaptability, Partnership, Growth, Affection and Resolve, Alcohol Use Disorder Identification Test and The Advance Warning of Relapse Questionnaire were used in the current study. Alpha coefficients and correlation matrix for all variables were computed. Moderation analysis further revealed that perceived stigma significantly moderated the relationship between drug and alcohol abuse severity and warning of relapse. The family function also moderated the relationship between drug and alcohol abuse severity and the sign of degeneration. It was found that Perceived stigma significantly moderated the relationship between alcohol and drug abuse severity and warning of relapse.

References

S. Khan, “Abuse Drug Addictive’s: Beginning and Causes of Drug among Different Gender in District Charsadda, Pakistan,” J. Alcohol. Drug Abus. Subst. Depend., vol. 7, no. 1, pp. 1–4, Jun. 2021, doi: 10.24966/ADSD-9594/100023.

M. Ali and N. S. Goraya, “Increasing Trend of Substance Using among Females of Punjab,” Pakistan J. Public Heal., vol. 11, no. 3, pp. 194–200, Oct. 2021, doi: 10.32413/PJPH.V11I3.759.

T. Rahman, M. D. G. Hasnain, and A. Islam, “Food insecurity and mental health of women during COVID-19: Evidence from a developing country,” PLoS One, vol. 16, no. 7, p. e0255392, Jul. 2021, doi: 10.1371/JOURNAL.PONE.0255392.

D. L. Biancarelli et al., “Strategies used by people who inject drugs to avoid stigma in healthcare settings,” Drug Alcohol Depend., vol. 198, no. January 2021, pp. 80–86, 2019, doi: 10.1016/j.drugalcdep.2019.01.037.

N. Topkaya, E. Şahin, A. K. Krettmann, and C. A. Essau, “Stigmatization of people with alcohol and drug addiction among Turkish undergraduate students,” Addict. Behav. Reports, vol. 14, no. October, 2021, doi: 10.1016/j.abrep.2021.100386.

E. Wood and M. Elliott, “Opioid Addiction Stigma: The Intersection of Race, Social Class, and Gender,” https://doi.org/10.1080/10826084.2019.1703750, vol. 55, no. 5, pp. 818–827, Mar. 2019, doi: 10.1080/10826084.2019.1703750.

J. Wogen and M. T. Restrepo, “Human Rights, Stigma, and Substance Use,” Health Hum. Rights, vol. 22, no. 1, p. 51, Jun. 2020, Accessed: Aug. 22, 2022. [Online]. Available: /pmc/articles/PMC7348456/

K. Goodyear and D. Chavanne, “Sociodemographic Characteristics and the Stigmatization of Prescription Opioid Addiction,” J. Addict. Med., vol. 14, no. 2, pp. 150–155, Mar. 2020, doi: 10.1097/ADM.0000000000000552.

D. Wasserman, M. Iosue, A. Wuestefeld, and V. Carli, “Adaptation of evidence-based suicide prevention strategies during and after the COVID-19 pandemic,” World Psychiatry, vol. 19, no. 3, pp. 294–306, Oct. 2020, doi: 10.1002/WPS.20801.

S. Vadher et al., “Burden of care in caregivers of patients with alcohol use disorder and schizophrenia and its association with anxiety, depression and quality of life,” Gen. Psychiatry, vol. 33, no. 4, pp. 1–9, 2020, doi: 10.1136/gpsych-2020-100215.

D. P. Goldberg and V. F. Hillier, “A scaled version of the General Health Questionnaire,” Psychol. Med., vol. 9, no. 1, pp. 139–145, 1979, doi: 10.1017/S0033291700021644.

R. L. Spitzer et al., “Utility of a New Procedure for Diagnosing Mental Disorders in Primary Care: The PRIME-MD 1000 Study,” JAMA J. Am. Med. Assoc., vol. 272, no. 22, pp. 1749–1756, 1994, doi: 10.1001/jama.1994.03520220043029.

“Instrument: Drug Abuse Screening Test (DAST-10) | NIDA CTN Common Data Elements.” https://cde.drugabuse.gov/instrument/e9053390-ee9c-9140-e040-bb89ad433d69 (accessed Aug. 22, 2022).

J. B. Luoma, A. K. O’Hair, B. S. Kohlenberg, S. C. Hayes, and L. Fletcher, “The Development and Psychometric Properties of a New Measure of Perceived Stigma Toward Substance Users,” Subst. Use Misuse, vol. 45, no. 1–2, p. 47, 2010, doi: 10.3109/10826080902864712.

G. Smilkstein, “The family APGAR: a proposal for a family function test and its use by physicians.,” J. Fam. Pract., vol. 6, no. 6, pp. 1231–1239, 1978.

M. Piccinelli, “Alcohol use disorders identification test (AUDIT),” Epidemiol. Psichiatr. Soc., vol. 7, no. 1, pp. 70–73, 1998, doi: 10.1017/S1121189X00007144.

T. T. Gorski and M. Miller, “Counseling for relapse prevention,” p. 143, 1982.

K. Park, L. MinHwa, and M. Seo, “The impact of self-stigma on self-esteem among persons with different mental disorders,” Int. J. Soc. Psychiatry, vol. 65, no. 7–8, pp. 558–565, Nov. 2019, doi: 10.1177/0020764019867352.

K. A. Crapanzano, R. Hammarlund, B. Ahmad, N. Hunsinger, and R. Kullar, “The association between perceived stigma and substance use disorder treatment outcomes: a review,” Subst. Abuse Rehabil., vol. 10, pp. 1–12, Dec. 2018, doi: 10.2147/SAR.S183252.

H. A. Demirtaş-Madran, “Accepting Restrictions and Compliance With Recommended Preventive Behaviors for COVID-19: A Discussion Based on the Key Approaches and Current Research on Fear Appeals,” Front. Psychol., vol. 12, no. June, pp. 1–15, 2021, doi: 10.3389/fpsyg.2021.558437.